Premium
Transfusion practices in the care of pregnant women with sickle cell disease in Ouagadougou
Author(s) -
Zamané Hyacinthe,
Sanou Fabienne,
Kiemtoré Sibraogo,
Kain Dantola Paul,
Sawadogo Arnaud Kiswendsida,
BonanéThiéba Blandine
Publication year - 2019
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12961
Subject(s) - medicine , pregnancy , exchange transfusion , blood transfusion , obstetrics , disease , pediatrics , group b , fetus , genetics , biology
Objective To study the contribution of blood transfusion management in the improvement of maternal and perinatal outcomes in pregnant women with sickle cell disease in Ouagadougou. Methods A cross‐sectional retrospective study with data collected from February 2012 to January 2014 was used. Patients were differentiated into three groups: patients with at least one exchange transfusion, patients who received blood transfusion, and patients who did not receive any transfusion. Data were collected from patients’ patient care documents. Results One hundred and sixty‐four patients were included, of whom 53 were in the first group, 32 in the second group, and 79 in the third group. Maternal complications in the last trimester of pregnancy were significantly less important ( P =0.000) in the first group (58.5%) than in the second (78.5%) and third group (91.1%). The same trend was observed for postpartum maternal mortality (5.7%; 12.5%; 12.6%; P =0.009). Fetal complications such as preterm birth and early neonatal death were lower in the first group (15.1%; 1.8%) than in the second (40.6%; 23.1%) and third group (32.9%; 7.6%). Conclusion Prophylactic blood transfusion is an important part of the management of pregnant patients with sickle cell disease.